×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AHKSY – asahi kaisei crp unsp/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AHKSY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
09:28 am
ahksy
Technical Textiles Company Evaluation Report 2025: Material Science Leaders Asahi Kasei, DuPont and Freudenberg Drive Innovation and Sustainable Growth [Yahoo! Finance]
Low
Report
Technical Textiles Company Evaluation Report 2025: Material Science Leaders Asahi Kasei, DuPont and Freudenberg Drive Innovation and Sustainable Growth [Yahoo! Finance]
3/5
07:56 am
ahksy
Asahi Kasei (AHKSY) was upgraded by The Goldman Sachs Group, Inc. from "hold" to "strong-buy".
Low
Report
Asahi Kasei (AHKSY) was upgraded by The Goldman Sachs Group, Inc. from "hold" to "strong-buy".
3/4
09:12 pm
ahksy
????????????????? - ??????????????????2026-2035? [CNET News]
Low
Report
????????????????? - ??????????????????2026-2035? [CNET News]
3/3
03:25 pm
ahksy
New Clinical Study Highlights Durable, Robust Immune Response of Participants Using Turkey Tail Paired with Agarikon Mushroom Mycelium [Yahoo! Finance]
Low
Report
New Clinical Study Highlights Durable, Robust Immune Response of Participants Using Turkey Tail Paired with Agarikon Mushroom Mycelium [Yahoo! Finance]
2/27
07:27 am
ahksy
Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m [Yahoo! Finance]
Low
Report
Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m [Yahoo! Finance]
2/26
07:49 pm
ahksy
Assessing Asahi Kasei (TSE:3407) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Asahi Kasei (TSE:3407) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]
2/26
07:38 am
ahksy
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris [Yahoo! Finance]
Low
Report
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris [Yahoo! Finance]
2/26
07:30 am
ahksy
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris
Low
Report
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
ZOLL Executing a Plan to Build 10,000 Ventilators/Month in Response to COVID-19 Pandemic
6.8%
11/25 Asahi Kasei makes $1.3 billion offer for stake in Denmark's Veloxis [Reuters] 6.2%
10/9 Developers of lithium-ion batteries win Nobel Prize in Chemistry [Toronto Globe and Mail (Ontario, Canada)] 5.4%
1/28 ASAHI KASEI COR/ADR (OTCMKTS: AHKSY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.9%
1/14 Scripps La Jolla First in U.S. to Use ZOLL’s FDA-approved Supersaturated Oxygen Therapy on Patients Suffering From Widowmaker Heart Attacks 2.8%
6/11 ZOLL Signs Definitive Agreement to Purchase Cardiac Science 2.6%
3/30 FDA Approves Next-Generation ZOLL® TherOx System for Widowmaker Heart Attack Patients 1.9%
1/1 Nobel for a Battery Breakthrough Was Decades in the Making [Yahoo! Finance News] 1.4%
6/18 Zoll Medical Corporation Acquires TherOx, Inc. 0.7%
6/10 Zoll Introduces New Technology to Improve the Management of Acute Heart Failure Patients 0.7%
11/25 Asahi Kasei makes $1.3 billion offer for stake in Denmark's Veloxis [Reuters] 6.2%
10/9 Developers of lithium-ion batteries win Nobel Prize in Chemistry [Toronto Globe and Mail (Ontario, Canada)] 5.4%
1/28 ASAHI KASEI COR/ADR (OTCMKTS: AHKSY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.9%
1/14 Scripps La Jolla First in U.S. to Use ZOLL’s FDA-approved Supersaturated Oxygen Therapy on Patients Suffering From Widowmaker Heart Attacks 2.8%
6/11 ZOLL Signs Definitive Agreement to Purchase Cardiac Science 2.6%
3/30 FDA Approves Next-Generation ZOLL® TherOx System for Widowmaker Heart Attack Patients 1.9%
1/1 Nobel for a Battery Breakthrough Was Decades in the Making [Yahoo! Finance News] 1.4%
6/18 Zoll Medical Corporation Acquires TherOx, Inc. 0.7%
6/10 Zoll Introduces New Technology to Improve the Management of Acute Heart Failure Patients 0.7%
TOP News Decliners
3/31
ASAHI KASEI COR/ADR (OTCMKTS: AHKSY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
-5.6%
3/28 How a College Final Became a Lesson in Survival [The New York Times] -2.8%
10/9 The Science Behind The Lithium-Ion Battery Research That Won 2019’s Nobel Prize In Chemistry [Forbes] -2.4%
10/9 If You’re Reading This On Your Phone, Thank Today’s New Nobelists [Forbes] -2.2%
8/7 ASAHI KASEI COR/ADR (OTCMKTS: AHKSY) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -0.8%
8/27 ZOLL Medical Completes Acquisition of Cardiac Science -0.5%
11/11 AI company AiCure takes in $24.5 mln Series C [Reuters] -0.2%
7/22 ZOLL Acquires Mobilize RRS LLC. -0.1%
3/28 How a College Final Became a Lesson in Survival [The New York Times] -2.8%
10/9 The Science Behind The Lithium-Ion Battery Research That Won 2019’s Nobel Prize In Chemistry [Forbes] -2.4%
10/9 If You’re Reading This On Your Phone, Thank Today’s New Nobelists [Forbes] -2.2%
8/7 ASAHI KASEI COR/ADR (OTCMKTS: AHKSY) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -0.8%
8/27 ZOLL Medical Completes Acquisition of Cardiac Science -0.5%
11/11 AI company AiCure takes in $24.5 mln Series C [Reuters] -0.2%
7/22 ZOLL Acquires Mobilize RRS LLC. -0.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: